Jakobson, T <br/><br/>
Experience with phenylethylbiguanide (DBI) tablets and timed-disintegration capsules (DBI-TD) administered as an adjunct to insulin or sulfonylurea drugs in previously treated diabetic patients.  [electronic resource] 

 -  Annales medicinae internae Fenniae  1965 
 - 109-16 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0365-4362 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Child<br/>Delayed-Action Preparations<br/>Diabetes Mellitus--drug therapy<br/>Drug Synergism<br/>Female<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Insulin--therapeutic use<br/>Male<br/>Middle Aged<br/>Phenformin--therapeutic use